Variation of a gene may have a role in protecting cancer patients from developing chemotherapy-induced cognitive impairment, commonly known as ‘chemofog’ or ‘chemobrain,’ a team of researchers has established.
Variation of a gene may have a role in protecting cancer patients from developing chemotherapy-induced cognitive impairment, commonly known as ‘chemofog’ or ‘chemobrain,’ a team of researchers has established.